Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Arcus Biosciences, Inc. (RCUS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 21,369 shares
@ $19.99, valued at
$427.2k
|
|
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Azoy Alexander (Chief Accounting Officer) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 1,018 shares
@ $20.41, valued at
$20.8k
|
|
| 06/30/2023 |
4
| GILEAD SCIENCES, INC. (10% Owner) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Bought 1,010,000 shares
@ $19.26, valued at
$19.5M
|
|
| 06/16/2023 |
4
| Tang Carolyn C. (General Counsel) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Disposed/sold 2,892 shares
@ $19.35, valued at
$56k
|
|
| 06/16/2023 |
4
| Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 12,563 shares
@ $19.35, valued at
$243.1k
|
|
| 06/16/2023 |
4
| Jaen Juan C. (President) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Gifted 6,000 shares
@ $0
Disposed/sold 4,820 shares
@ $19.35, valued at
$93.3k
|
|
| 06/16/2023 |
4
| ROSEN TERRY J (CEO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Disposed/sold 8,762 shares
@ $19.35, valued at
$169.5k
|
|
| 06/16/2023 |
4
| Lambert Nicole (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/16/2023 |
4
| PERLMAN ANDREW J (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/16/2023 |
4
| Lacey David L. (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/16/2023 |
4
| Ribas Antoni (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/16/2023 |
4
| Machado Patrick (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/16/2023 |
4
| KANEKO YASUNORI (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/16/2023 |
4
| FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Gifted 50,504 shares
@ $0
Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/09/2023 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 4,049 shares
@ $20.04, valued at
$81.1k
|
|
| 03/20/2023 |
4
| Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 8,729 shares
@ $16.81, valued at
$146.7k
|
|
| 03/10/2023 |
3
| Azoy Alexander (Chief Accounting Officer) has filed a Form 3 on Arcus Biosciences, Inc. |
| 01/30/2023 |
4
| Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 300 shares
@ $23.56, valued at
$7.1k
Sold 1,600 shares
@ $23.52, valued at
$37.6k
|
|
| 01/25/2023 |
4
| Nuyten Dimitry SA (Chief Medical Officer) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 34,000 shares
@ $0
Granted 138,200 options to buy
@ $22.02, valued at
$3M
|
|
| 01/25/2023 |
4
| Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 34,000 shares
@ $0
Granted 138,200 options to buy
@ $22.02, valued at
$3M
|
|
| 01/25/2023 |
4
| Tang Carolyn C. (General Counsel) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 34,000 shares
@ $0
Granted 138,200 options to buy
@ $22.02, valued at
$3M
|
|
| 01/25/2023 |
4
| Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 45,800 shares
@ $0
Granted 185,900 options to buy
@ $22.02, valued at
$4.1M
|
|
| 01/25/2023 |
4
| Jaen Juan C. (President) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 45,800 shares
@ $0
Granted 185,900 options to buy
@ $22.02, valued at
$4.1M
|
|
| 01/25/2023 |
4
| ROSEN TERRY J (CEO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 105,700 shares
@ $0
Granted 429,000 options to buy
@ $22.02, valued at
$9.4M
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| ROSEN TERRY J (CEO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 10,983 shares
@ $30.66, valued at
$336.7k
Sold 2,060 shares
@ $31.23, valued at
$64.3k
|
|
| 09/20/2022 |
4
| Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 12,677 shares
@ $26.28, valued at
$333.2k
|
|
| 08/24/2022 |
4
| Nuyten Dimitry SA (Chief Medical Officer) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 42,500 shares
@ $0
Granted 170,000 options to buy
@ $26, valued at
$4.4M
|
|
| 08/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/21/2022 |
4
| Tang Carolyn C. (General Counsel) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Sold 1,400 shares
@ $20.72, valued at
$29k
Sold 449 shares
@ $21.71, valued at
$9.7k
Sold 1,073 shares
@ $22.29, valued at
$23.9k
|
|
|
|
|